In the Clinic
By Esther Napolitano, BS, Science Writer/Editor | Monday, May 21, 2012
Results of an international study indicate that the investigational drug tivozanib is more effective and better tolerated than a currently approved therapy in delaying cancer growth.
By Memorial Sloan-Kettering | Friday, May 18, 2012
As part of Memorial Sloan-Kettering’s 33rd annual academic convocation on May 11, the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences awarded PhDs to four graduates.
By Media Staff | Thursday, May 17, 2012
Memorial Sloan-Kettering was one of the first centers to use this type of genetic testing for lung cancer patients and is currently one of the only centers testing for mutations in squamous cell carcinomas of the lung.
By Memorial Sloan-Kettering | Monday, May 14, 2012
Dr. Coleman, who specializes in treating prostate and kidney cancers, talks about how minimally invasive surgical techniques reduce recovery time and pain, as well as improve quality of life for patients.
By Memorial Sloan-Kettering | Friday, May 11, 2012
Research at Memorial Sloan-Kettering will benefit from renewed support for The Starr Cancer Consortium and the Tri-Institutional Stem Cell Initiative totaling $105 million.
By Memorial Sloan-Kettering | Wednesday, May 9, 2012
Six nursing staff members were named the 2012 Samuel and May Rudin Award winners at an early morning ceremony today.
By Memorial Sloan-Kettering | Monday, May 7, 2012
Dr. Jarnagin – a surgeon who treats patients with disorders of the pancreas, liver, and bile ducts – discusses the specialized expertise of surgeons at Memorial Sloan-Kettering, a high-volume center.
By Memorial Sloan-Kettering | Thursday, May 3, 2012
Dr. Rusch, Chief of the Thoracic Service, discusses the multidisciplinary care plan that is developed for each patient by a specialized team of physicians at Memorial Sloan-Kettering.
In the Clinic
By Eva Kiesler, PhD, Science Writer/Editor | Monday, April 30, 2012
Memorial Sloan-Kettering researchers have found that people in the late stages of cancer might benefit from meaning-centered psychotherapy, a treatment aimed at helping people sustain a sense of meaning and purpose.
By Memorial Sloan-Kettering | Friday, April 27, 2012
Dr. Van Zee discusses the personalized care delivered by a multidisciplinary team of breast cancer experts at Memorial Sloan-Kettering.
In the Lab
By Julie Grisham, MS, Science Writer/Editor | Wednesday, April 25, 2012
Researchers have demonstrated a technique that enables specific and accurate labeling of brain tumor tissue in mice. If proven effective in patients, the method could make complete surgical removal of brain tumors more feasible.
By Memorial Sloan-Kettering | Monday, April 23, 2012
Patty grew up playing in the sun at the beach, so when she developed a growth under her eye she knew it could be skin cancer. Experts at Memorial Sloan-Kettering Basking Ridge diagnosed her with basal cell carcinoma and performed a highly specialized surgery to remove the cancer.
In the News
By Media Staff | Friday, April 20, 2012
In an article describing the history and promise of immunotherapy for cancer treatment, the magazine highlights the groundbreaking work of James Allison, Chair of the Sloan-Kettering Institute’s Immunology Program, and medical oncologist and immunologist Jedd Wolchok.
By Memorial Sloan-Kettering | Wednesday, April 18, 2012
Explore our newly updated guide to testicular cancer care to learn about how our specialists work as a team to diagnose and treat men with this type of cancer.
By Memorial Sloan-Kettering | Monday, April 16, 2012
James Eastham, Chief of Memorial Sloan-Kettering’s Urology Service, talks about how our prostate cancer experts collaborate to maximize the likelihood of curing the cancer and limiting the side effects of treatment.